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Abstract
IMPORTANCE Body mass index (BMI) is positively associated with blood pressure (BP); this
association has critical implications for countries like China, where hypertension is highly prevalent
and obesity is increasing. A greater understanding of the association between BMI and BP is required
to determine its effect and develop strategies to mitigate it.

Key Points
Question How does increasing body
mass index affect the prevalence of
hypertension and cardiovascular health
in different groups of people in China?
Findings In this population-based

OBJECTIVE To assess the heterogeneity in the association between BMI and BP across a wide

cross-sectional study, the association

variety of subgroups of the Chinese population.

between body mass index and blood
pressure was consistent and positive

DESIGN, SETTING, AND PARTICIPANTS In this cross-sectional study, data were collected at 1 time

across more than 20 000 subgroups of

point from 1.7 million adults (aged 35-80 years) from 141 primary health care sites (53 urban districts

1.7 million Chinese adults and was only

and 88 rural counties) from all 31 provinces in mainland China who were enrolled in the China PEACE

substantially affected by treatment with

(Patient-Centered Evaluative Assessment of Cardiac Events) Million Persons Project, conducted

antihypertensive medication.

between September 15, 2014, and June 20, 2017. A comprehensive subgroup analysis was performed
by defining more than 22 000 subgroups of individuals based on covariates, and within each
subgroup, linearly regressing BMI to BP.

Meaning Trends in increasing body
mass index may lead to increases in
blood pressure and cardiovascular
events, suggesting the need for

MAIN OUTCOMES AND MEASURES Systolic BP was measured twice with the participant in a
seated position, using an electronic BP monitor.

measures of better prevention of this
increase, as well as mitigation of
hypertension with treatment and

RESULTS The study included 1 727 411 participants (1 027 711 women and 699 700 men; mean [SD]

lifestyle measures.

age, 55.7 [9.8] years). Among the study sample, the mean (SD) BMI was 24.7 (3.5), the mean (SD)
systolic BP was 136.5 (20.4) mm Hg, and the mean (SD) diastolic BP was 81.1 (11.2) mm Hg. The
increase of BP per unit BMI ranged from 0.8 to 1.7 mm Hg/(kg/m2) for 95% of the subgroups not
taking antihypertensive medication. The association between BMI and BP was substantially weaker
in subgroups of patients taking antihypertensive medication compared with those who were
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untreated. In untreated subgroups, 95% of the coefficients varied by less than 1 mm Hg/(kg/m2).
CONCLUSIONS AND RELEVANCE The association between BMI and BP is positive across tens of
thousands of individuals in population subgroups, and, if causal, given its magnitude, would have
significant implications for public health.
JAMA Network Open. 2018;1(4):e181271. doi:10.1001/jamanetworkopen.2018.1271

Introduction
Body mass index (BMI) is positively associated with both systolic blood pressure (SBP) and diastolic
blood pressure (DBP).1-5 Weight loss significantly reduces blood pressure (BP),6-8 suggesting that
BMI is not merely a marker of factors associated with high BP but is causally associated.9-11 One
implication of this association is that elevated BP, a major cardiovascular disease risk factor, will
become an even more dominant health challenge as BMI continues to increase.
Open Access. This is an open access article distributed under the terms of the CC-BY License.
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The association between BMI and BP has important implications in countries such as China,
where hypertension is already common and the prevalence of obesity is projected to more than triple
in men (from 4.0% to 12.3%) and more than double in women (from 5.2% to 10.8%) by 2025, as
compared with 2010.12 To understand this association and the strategies to mitigate it requires a
greater understanding of the nature of the association of BMI with BP and any heterogeneity in the
association across diverse subgroups. In particular, it is important to go beyond simple stratifications
of a few demographic characteristics and investigate subgroups defined by their age, sex, race/
ethnicity, geography, occupation, and other pertinent characteristics. To our knowledge, studies
have not addressed how consistent the association between BMI and BP is across such a diversity
of groups.
Accordingly, we used data from a study of 1.7 million participants from China-PEACE (PatientCentered Evaluative Assessment of Cardiac Events) Million Persons Project,13 a nationwide Chinese
screening project, to systematically assess the nature of the association between BMI and BP and
how it varies across a wide variety of subgroups of the population. Such knowledge could suggest
ways to target interventions, provide insight into mechanisms, and project future health care needs.
This issue is particularly germane to the fifth of the world’s population in China but also has general
relevance because many countries experience trends of increasing weight and face challenges with
hypertension.

Methods
Participants and Study Design
The design and conduct of the China-PEACE Million Persons Project have been previously described
in detail.13 In brief, the China-PEACE Million Persons Project is a national, population-based screening
project funded by the Chinese government to identify individuals at high risk of cardiovascular
disease and to collect research-grade data and biospecimens from this population. From September
15, 2014, to June 20, 2017, we used a convenience sampling strategy to select 141 primary health care
sites (88 rural counties and 53 urban districts) from all 31 provinces in mainland China. In each site,
5 towns or subdistricts were chosen according to their size and population stability. In each town or
subdistrict, potential participants were invited by local staff via extensive publicity campaigns on
television and in the newspaper. Participants were enrolled if they were between the ages of 35 and
80 years and could confirm their residence in a selected region. On enrollment, participants were
screened for high risk of cardiovascular disease using measurements including weight, height, BP,
serum lipid levels, and a questionnaire evaluating general health status. An interviewer measured
each participant’s BP twice with the participant in a seated position after 5 minutes of rest, using an
electronic BP monitor (Omron HEM-7430; Omron Corp) on the right upper arm, with a 1-minute
delay between measurements. If the difference between the 2 SBP measurements exceeded 10 mm
Hg, a third measurement was taken, and the mean of the last 2 measurements was used. The
participant’s weight and height without shoes and wearing light clothing were then measured by
trained technicians. Body mass index was then calculated as weight in kilograms divided by height in
meters squared. In addition to physical measurements, sociodemographic data and data on basic
medical history were collected from standardized in-person interviews by trained medical staff. At
present, data have been collected from 1 822 229 participants aged 35 to 80 years at 1 time point.
The data collection period covered only 39 months, precluding a trend analysis. We excluded
participants with missing or obviously erroneous data or those belonging to ethnic groups with fewer
than 5000 participants, resulting in a group of 1 727 411 individuals. The central ethics committee at
the China National Center for Cardiovascular Disease approved this project, and the institutional
review board at Yale University reviewed the study and waived the requirement for informed
consent. The study was reported in accordance with the Strengthening the Reporting of
Observational studies in Epidemiology (STROBE) reporting guideline.
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Statistical Analysis
All statistical analyses were conducted using R, version 3.3 (The R Foundation for Statistical
Computing). The proportion of individuals with stage 1 hypertension (SBP ⱖ140 mm Hg or DBP ⱖ90
mm Hg) and stage 2 hypertension (SBP ⱖ160 mm Hg or DBP ⱖ100 mm Hg), as classified by JNC 7
(the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure),14 are reported. The association between BMI and BP was
analyzed for subgroups of greater than 5000 patients, defined by sex, age, household income,
occupation, race/ethnicity, marital status, “Hukou” status (urban vs rural vs unified residence status),
province, educational level, currently smoking, history of stroke, and antihypertensive treatment
status. The smoothed conditional mean of BMI given BP for these subgroups was fit with an
unadjusted generative additive model to visually explore the linearity of the association between BMI
and BP. Generative additive models were chosen owing to their scalability; while local regression
methods (ie, Loess) can also fit nonlinear curves, they do not scale well beyond several
thousand points.
Separately, the coefficient of BMI when linearly regressed to SBP was reported as the increase
of SBP per 1 unit of BMI. An adjusted increase of SBP per 1 unit of BMI was computed by linear
regression, including the following covariates in the regression model: sex, age, household income,
occupation, race/ethnicity, marital status, Hukou status (urban vs rural vs unified residence status),
province, educational level, currently smoking, history of stroke, and antihypertensive treatment
status. All these variables are categorical except age, which was not discretized when added as a
covariate. When computing an adjusted linear regression model for a subgroup, we excluded the
variable defining that subgroup from the model. Adjusted and unadjusted increases in DBP per 1 unit
of BMI were also similarly computed.
Because the distribution of SBP is expected to be different between patients taking
antihypertensive medications and those not taking antihypertensive medications, we also compared
the association of BMI with BP between these 2 groups after matching their distribution of SBP.
Specifically, we used a histogram-based density estimation (100 equal-width bins) to estimate the
distribution of SBP in both groups, and we subsampled the group of patients not taking medication
such that the distribution of SBP in the resulting group would match that of patients taking
antihypertensive medications. The association between BMI and BP was then compared between
the group of patients taking medications and the matched subgroup of patients not taking
medications.
To further explore whether and how the association between BMI and BP varies across
population subgroups, we calculated the coefficient of BMI when regressed to SBP (ie, the increase
in SBP [mm Hg] per 1 kg/m2 of BMI) for subgroups defined by all possible combinations of the
covariates. In this comprehensive subgroup analysis, we defined subgroups by all possible
combinations of up to 6 of 10 selected characteristics: age (35-50, 51-60, 61-70, and 71-80 years), sex
(men or women), ethnicity (Han, Mongol, Hui, Tibet, Uygher, Miao, Yi, Zhuang, Korean, Man, Dong,
and Tujia), Hukou status (urban vs rural vs unified residential status), marital status (married or
unmarried), occupation (farmer, worker, administrator, administrative clerk, technician, business,
business owner, military, other, and retired), annual household income (<¥10 000 [equivalent to
$1452], ¥10 000-¥50 000 [$1452-$7259], and ⱖ¥50 000 [$7259]), educational level (illiterate,
less than primary school, homeschool, elementary school, middle school, high school, vocational
school, associate degree, bachelor degree, master’s degree, doctoral degree, and no answer),
antihypertension treatment status (treated vs untreated), and province. For example, a possible
subgroup defined by age, sex, and treatment status could be women 51 to 60 years of age who are
not taking antihypertensive medication. We retained subgroups of more than 10 000 people,
calculated the linear regression coefficient and Spearman rank correlation coefficient of BMI to SBP
and to DBP, and plotted the distribution of these coefficients as histograms.
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All confidence intervals correspond to 95% CIs, as computed from the SE. The data that support
the findings of this study are available from L.J. upon reasonable request and funding for
deidentification of protected health information in the study.

Results
BMI and BP
Our analysis includes 1 727 411 participants (1 027 711 women and 699 700 men), with a mean (SD)
age of 55.7 (9.8) years. Among the study sample, the mean (SD) BMI was 24.7 (3.5), the mean (SD)
SBP was 136.5 (20.4) mm Hg, and the mean (SD) DBP was 81.1 (11.2) mm Hg (eFigure 1 in the
Supplement). The prevalence of hypertension (SBP ⱖ140 mm Hg or DBP ⱖ90 mm Hg) was 41.6%
(n = 718 714), and the prevalence of stage 2 hypertension (SBP ⱖ160 mm Hg or DBP ⱖ100 mm Hg)
was 15.3% (n = 263 695). Furthermore, 36 201 participants (2.1%) were underweight (BMI <18.5),
952 471 participants (55.1%) were normal weight (BMI 18.5-24.9), 622 207 participants (36.0%) were
overweight (BMI 25.0-29.9), and 116 532 participants (6.7%) were obese (BMI ⱖ30), as defined by
the World Health Organization international classification.15

Association Between BMI and BP Overall and in Population Subgroups
The association between BP and BMI in the overall sample is positive and linear from a BMI of 18.5 to
30.0 (Figure 1), with an unadjusted increase in SBP per unit BMI of 1.37 (95% CI, 1.35-1.93) mm
Hg/(kg/m2), an adjusted increase in SBP per unit BMI of 1.15 (95% CI, 1.13-1.17) mm Hg/(kg/m2), an
unadjusted increase in DBP per unit BMI of 0.85 (95% CI, 0.84-0.86) mm Hg/(kg/m2), and an
adjusted increase in DBP per unit BMI of 0.75 (95% CI, 0.74-0.76) mm Hg/(kg/m2).
The association of BMI with SBP (Figure 2 and Figure 3) and DBP (eFigure 2 in the Supplement)
was consistently positive across 86 subgroups defined by sociodemographic variables and was
nearly linear, with little variation in its shape. The positive, nearly linear association between BMI and
BP across sex, age, household income, occupation, race/ethnicity, marital status, Hukou status,
province, educational level, smoking status, and history of stroke is qualitatively similar (eTable 1 in
the Supplement). Furthermore, the estimated unadjusted increase in SBP per unit BMI is between 1.0
and 1.9 mm Hg/(kg/m2) for nearly all subgroups. The only 2 exceptions are individuals from the
province of Tibet, with an unadjusted increase in SBP per unit BMI of 0.56 (95% CI, 0.44-0.68) mm
Hg/(kg/m2), and individuals taking antihypertensive medications, with an unadjusted increase in SBP
per unit BMI of 0.34 (95% CI, 0.29-0.39) mm Hg/(kg/m2).

Figure 1. Scatterplots of Body Mass Index Against Blood Pressure (BP)
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The distribution of regression coefficients of BMI to SBP across all 22 333 subgroups reveals 2
modes, each corresponding to subgroups defined by treated patients and untreated patients
(Figure 4). A similar distribution is also observed for the Spearman correlation between BMI and BP
for each subgroup (eFigure 3 in the Supplement). The same 2 modes are also observed for regression
coefficients of BMI to DBP. The association between BMI and BP in subgroups in which individuals
were taking antihypertensive medications (95% of the coefficients ranging from 0.2 to 0.6 mm
Hg/[kg/m2]) is substantially smaller compared with subgroups in which individuals were not taking
antihypertensive medications (95% of the coefficients ranging from 0.8 to 1.7 mm Hg/[kg/m2]). This
difference is also evident when comparing individuals taking medications with a matching group of
individuals not taking medications (eFigure 4 in the Supplement).

Discussion
This study provides a detailed description of the association between BMI and BP in a national
population-based study in China, which has important implications for the future of cardiovascular
risk. The association between BMI and BP is robust; despite dramatic differences in their individual
BP distributions, the association is similar across tens of thousands of subgroups, with implications
for the primary prevention of hypertension. In nearly all subgroups of individuals taking
antihypertensive medications, however, this association is attenuated, indicating, as expected, that
treatment mitigates the association of BMI with BP. Given these results, China and countries in a

Figure 2. Smoothed Conditional Mean of Systolic Blood Pressure (SBP) Given Body Mass Index (BMI) for Sex, Age, Income, Occupation, Race/Ethnicity,
and Marital Status
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similar position should not only focus on preventing the increase of BMI but also improve diagnosis
and treatment rates of hypertension to mitigate this emerging health threat.
Our study extends the literature in several ways. First, we identified the association of
increasing BMI with BP in a large, well-stratified Chinese population. Second, the unprecedented
number of individuals in our study allows us to study the association between BMI and BP in more
than 20 000 subgroups defined by combinations of covariates. In 95% of the subgroups not taking
antihypertensive medication, the coefficients varied by less than 1 mm Hg/(kg/m2), demonstrating
the stability of this association to an extent never previously explored, to our knowledge.
Furthermore, we extended recent trends of increasing BMI in China (eFigure 5 in the Supplement) to
project mean BMI in 2025, and assuming the association between BMI and BP remains the same, we
estimated the number of strokes and ischemic heart disease burden in 2025 attributable to the
associated increase in BP (eAppendices 1 and 2 in the Supplement). Assuming mean BMI in men and

Figure 3. Smoothed Conditional Mean of Systolic Blood Pressure (SBP) Given Body Mass Index (BMI) for Region, Province, Educational Level, Smoking Status,
Stroke History, and Antihypertensive Medication Use
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women increases from 24.9 and 24.3 in 2014 to 27.8 and 25.3 in 2025, the resulting increase in BP
could potentially lead to more than 300 000 cases of stroke (eTable 2 in the Supplement) and
350 000 cases of ischemic heart disease (eTable 3 in the Supplement) by 2025, highlighting the
disease burden attributable to the association of BMI with BP. This estimate assumes that the
association of increasing BMI with BP will persist, whether as a marker or mediator, as will the current
patterns of treatment. It is a rough estimate but indicates the possibility that China will be facing an
even larger challenge with hypertension in the future.
China and other countries experiencing an epidemiologic transition have 2 paths to mitigate the
increasing threat to cardiovascular health posed by increasing BMI. The first is to slow the increase
in BMI through public health interventions, and the second is through better treatment of
hypertension. Although many public health strategies have not yet been successful in slowing the
increase of BMI in adults,16 increasing the rates of treatment of hypertension is an attainable goal.
However, a recent study based on the China PEACE Million Persons Project reported that, among
people with hypertension, the rate of awareness of their hypertension was 36.0%, the rate of
treatment of their hypertension was 22.9%, and the rate of control of their hypertension was 5.7%.17
Moreover, many primary care clinics lack antihypertensive medications even though they are
identified by the government as essential medications.18 The implication is that better
antihypertensive treatment can play a crucial role in mitigating the health effects of increasing BMI in

Figure 4. Distributions of the Coefficients of Body Mass Index (BMI) When Regressed to Systolic Blood Pressure (SBP) or Diastolic Blood Pressure (DBP)
for Various Population Subgroups
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China and that efforts should be taken to promote the use of effective antihypertensive medication
among those with hypertension. In particular, the primary care and insurance systems in China
should be strengthened so as to reduce the barrier for antihypertensive treatment.
Our analysis of the general association between BMI and BP is generally consistent with
previous literature; for every 1-kg/m2 increase in BMI, our analysis shows a 1.3–mm Hg increase for
men and a 1.4–mm Hg increase for women, compared with a 1.4–mm Hg increase for men and a
1.2–mm Hg increase for women in a Western study19 and a 1.7–mm Hg increase for men and a 1.4–mm
Hg increase for women in a Chinese study.20 Furthermore, our finding that antihypertensive
treatment mitigates the association of BMI with SBP is consistent with a previous study of 500 000
Chinese individuals from 10 locales, in which the association between BMI and SBP was found to be
only one-third as strong in participants receiving antihypertensive medication.20

Limitations
Our study has several limitations. First, our study is based on cross-sectional data; therefore, unlike
studies that have shown that changes in BMI are independently associated with the incidence of
hypertension,1,21,22 we cannot establish a causal association between BMI and BP. Nevertheless,
based on prior literature, and especially data on the association of weight loss with BP, a causal
association seems quite plausible. Second, our comparison of the strength of association between
BMI and BP is based on comparing linear regression coefficients, which assumes a linear association.
Visualization of the association as fit by generative additive models suggests that the association is
fairly linear, and for the subgroups that we did not visualize, we validated our results using the
Spearman coefficient, which assumes only a monotonic association. Third, we cannot determine if
BMI is independently associated with BP, or if it is simply a surrogate for another variable. Many
factors could be the modifiers of the association between BMI and BP. For some people, an increased
BMI may be a result of diet or activity, a balance between diet and activity, or the result of a genetic
predisposition combined with some proportion of contribution by diet and/or activity. Taking
advantage of the large sample size of our study, we were able to show that the association of BMI
with BP was robust and that the coefficients were similar across subgroups. Although our study
cannot prove causation, as is true with observational, epidemiologic studies, it lays a foundation for
projections and for testing the outcome of interventions in a country in the middle of an
epidemiologic transition.

Conclusions
The association between BP and BMI is positive in the general population and in tens of thousands of
subgroups, suggesting that the trend of increasing BMI will be associated with the prevalence of
hypertension across nearly all segments of the population. Treatment of BP alters this association
and could play a critical role in mitigating the public health effect of increasing BMI, to complement
public health measures. The estimates of the potential association of BMI with stroke and ischemic
heart disease, which are based on the current pattern of treatment in this population, should signal
the need for addressing the future increase in the prevalence of hypertension as a national priority
in China and other countries experiencing a similar epidemiologic transition. Unless China markedly
slows the increase in BMI and/or improves its rates of treatment and control of hypertension, the
association of hypertension with cardiovascular risk is likely to cause hundreds of thousands more
myocardial infarctions and strokes as a result of projected increases in BMI and its association
with BP.
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